In the context of aging-related brain injury, pre-clinical studies have been describing the role of myeloperoxidase (MPO) in neurodegenerative diseases, such as Alzheimer's disease,11 Parkinson's disease,12 and multiple sclerosis.13 This evidence concerns the gene MPO and multiple sclerosis.